Vestal Point Capital, LP

Q3 2026 13F-HR Holdings

Location
New York, NY
Holdings as of
9/30/2026
Date filed
11/16/2026
Form type
13F-HR
Num holdings
63
Total value ($000)
$3,870,755
Net value change ($000)
-408,703 (-9.6%)
New positions
15
Sold out positions
20
Turnover %
25.0%
Sector allocation + QoQ delta (equities-only)

Snapshot: Change Analysis

Compared to Q2 2026
Methodology: sector metrics are equities-only; instrument mix chart is ex-options; options exposure is shown separately. Why this matters.
Top Adds (Value $000, Stocks/ETFs)
INSM 284,377 1066.9%
ARWR 186,764 145.5%
TARS 93,776 141.9%
ABVX 79,032 25.2%
Ascendis Pharma AS 68,574 68.6%
NBIX 37,754 11.9%
IMTX 35,783 57.2%
TVTX 35,328 NEW
RCUS 33,579 NEW
BBIO 26,320 NEW
Top Reduces (Value $000, Stocks/ETFs)
ABT -127,036 -100.0%
AZN -85,329 -100.0%
RVMD -84,276 -100.0%
BCRX -83,000 -100.0%
PODD -79,176 -77.6%
ZBH -78,332 -65.0%
SNY -64,705 -75.8%
ELVN -55,166 -27.2%
RGEN -54,576 -100.0%
BCAX -53,053 -34.0%
Instrument mix + QoQ Δ (ex-options)
How this table is calculated: SEC VALUE ($000) is used as reported. For derivatives (PUT/CALL/WARRANT/RIGHT), SEC value represents reported underlying exposure, not premium cash paid/received. Column % is bucket-based: non-options share is calculated inside non-option total, options share is calculated inside options total. Details.
Filter:
Instrument:
Issuer Name Ticker Sector Industry Class History Value ($000) % Shares Shares Δ Shares Δ% Value Δ ($000) Value Δ% Principal Option Type